Cite
MLA Citation
Fiona Hegi-Johnson et al.. “ImmunoPET: IMaging of cancer imMUNOtherapy targets with positron Emission Tomography: a phase 0/1 study characterising PD-L1 with 89Zr-durvalumab (MEDI4736) PET/CT in stage III NSCLC patients receiving chemoradiation study protocol.” BMJ open, vol. 12, no. 11, 2022, p. . http://access.bl.uk/ark:/81055/vdc_100169753272.0x000032